Quest Diagnostics EBITDA 2010-2024 | DGX
Quest Diagnostics annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Quest Diagnostics EBITDA for the quarter ending December 31, 2024 was $0.455B, a 0.44% increase year-over-year.
- Quest Diagnostics EBITDA for the twelve months ending December 31, 2024 was $1.719B, a 9.07% increase year-over-year.
- Quest Diagnostics 2024 annual EBITDA was $1.839B, a 8.11% increase from 2023.
- Quest Diagnostics 2023 annual EBITDA was $1.701B, a 8.79% decline from 2022.
- Quest Diagnostics 2022 annual EBITDA was $1.865B, a 33.13% decline from 2021.
Quest Diagnostics Annual EBITDA
(Millions of US $) |
| 2024 |
$1,839 |
| 2023 |
$1,701 |
| 2022 |
$1,865 |
| 2021 |
$2,789 |
| 2020 |
$2,332 |
| 2019 |
$1,560 |
| 2018 |
$1,410 |
| 2017 |
$1,435 |
| 2016 |
$1,526 |
| 2015 |
$1,703 |
| 2014 |
$1,297 |
| 2013 |
$1,758 |
| 2012 |
$1,488 |
| 2011 |
$1,268 |
| 2010 |
$1,538 |
| 2009 |
$1,616 |
Quest Diagnostics Quarterly EBITDA
(Millions of US $) |
| 2024-09-30 |
$455 |
| 2024-06-30 |
$472 |
| 2024-03-31 |
$416 |
| 2023-12-31 |
$376 |
| 2023-09-30 |
$453 |
| 2023-06-30 |
$460 |
| 2023-03-31 |
$412 |
| 2022-12-31 |
$251 |
| 2022-09-30 |
$500 |
| 2022-06-30 |
$495 |
| 2022-03-31 |
$619 |
| 2021-12-31 |
$642 |
| 2021-09-30 |
$753 |
| 2021-06-30 |
$633 |
| 2021-03-31 |
$761 |
| 2020-12-31 |
$893 |
| 2020-09-30 |
$807 |
| 2020-06-30 |
$372 |
| 2020-03-31 |
$260 |
| 2019-12-31 |
$445 |
| 2019-09-30 |
$395 |
| 2019-06-30 |
$388 |
| 2019-03-31 |
$332 |
| 2018-12-31 |
$301 |
| 2018-09-30 |
$381 |
| 2018-06-30 |
$382 |
| 2018-03-31 |
$346 |
| 2017-12-31 |
$342 |
| 2017-09-30 |
$367 |
| 2017-06-30 |
$385 |
| 2017-03-31 |
$341 |
| 2016-12-31 |
$339 |
| 2016-09-30 |
$385 |
| 2016-06-30 |
$483 |
| 2016-03-31 |
$319 |
| 2015-12-31 |
$313 |
| 2015-09-30 |
$708 |
| 2015-06-30 |
$376 |
| 2015-03-31 |
$306 |
| 2014-12-31 |
$336 |
| 2014-09-30 |
$335 |
| 2014-06-30 |
$343 |
| 2014-03-31 |
$283 |
| 2013-12-31 |
$342 |
| 2013-09-30 |
$758 |
| 2013-06-30 |
$361 |
| 2013-03-31 |
$297 |
| 2012-12-31 |
$337 |
| 2012-09-30 |
$376 |
| 2012-06-30 |
$405 |
| 2012-03-31 |
$370 |
| 2011-12-31 |
$389 |
| 2011-09-30 |
$395 |
| 2011-06-30 |
$390 |
| 2011-03-31 |
$94 |
| 2010-12-31 |
$346 |
| 2010-09-30 |
$401 |
| 2010-06-30 |
$429 |
| 2010-03-31 |
$362 |
| 2009-12-31 |
$393 |
| 2009-09-30 |
$412 |
| 2009-06-30 |
$425 |
| 2009-03-31 |
$386 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$19.317B |
$9.872B |
|
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
|
